Castleview Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Castleview Partners's ELV Position: Q1 2026 in Review
Castleview Partners reduced its Elevance Health (ELV) stake by 6.5% in Q1 2026, selling an estimated $115K and leaving 5,056 shares worth $1.48M. The position accounts for 0.76% of the portfolio, ranked #28.
Castleview Partners first reported a position in ELV in Q2 2021 and has held it in 13 quarters since. The position peaked at $2.15M in Q3 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Castleview Partners held 5,056 shares of Elevance Health worth $1.48M as of Q1 2026.
- Castleview Partners sold 350 Elevance Health shares in Q1 2026, an estimated $115K.
- Elevance Health made up 0.76% of Castleview Partners's portfolio in Q1 2026, its #28 holding.
- Castleview Partners first reported a position in Elevance Health in Q2 2021 and has held it in 13 quarters since.
- Castleview Partners's Elevance Health position peaked at $2.15M in Q3 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Castleview Partners's 13F filing for Q1 2026, filed 1 May 2026.